FACTS:
CVDs (Cardiovascular diseases) are the leading causes of death and disability in the world. Although a large proportion of CVDs is preventable, they continue to rise mainly because preventive measures are inadequate.
An estimated 17.3 million people died from CVDs in 2008. By 2030, almost 23.6 million people will die from CVDs.
In Pakistan, the prevalence of hypertension is quite high. It is estimated that over the age of 45 every third person is suffering from hypertension.
HYPERTENSION:
About 90–95% of cases are categorized as "primary hypertension" which means high blood pressure with no obvious underlying medical cause. The remaining 5–10% of cases (secondary hypertension) is caused by other conditions that affect the kidneys, arteries, heart or endocrine system.
Hypertension is a major risk factor for stroke, myocardial infarction (heart attacks), heart failure, aneurysms of the arteries, peripheral arterial disease and is a cause of chronic kidney disease.
THROMBOSIS:
Thrombosis, both arterial and venous is a major cause of morbidity and mortality worldwide. With respect to the arteries, most heart attacks and many strokes are triggered by thrombosis secondary to disrupted atherosclerosis plaque.
OUR APPROACH:
Graton Pharma is highly aware of these unmet needs and is committed for marketing the medicines that are effective in the management and treatment of cardiovascular diseases.
OUR PRODUCTS:
- Nitrop: (Sodium nitroprusside) has potent vasodilating effects in arterioles and venules that is indicated for the immediate reduction of blood pressure of patients in hypertensive crises.Nitrop(Sodium nitroprusside) remains an effective drug in certain clinical circumstances such as malignant hypertension or for rapid control of blood pressure during vascular surgery and neurosurgery.
- Name of manufacturer: Youcare Pharmaceutical Group Co.Ltd.
Beijing, China
- Ozac: (Ozagrel sodium) is an anti-thrombotic agent (selective Thromboxane A2 Synthase Inhibitor).It blocks platelet activation by targeting TXA2 pathway and its receptors. It prevents platelet aggregation and vasoconstriction in the cerebral ischemia. It plays an important role in the prevention of brain damage induced by cerebral ischemia/reperfusion and also treats unstable angina.
- Name of manufacturer: Youcare Pharmaceutical Group Co.Ltd.
Beijing, China
|
